Coya Therapeutics Statistics Share Statistics Coya Therapeutics has 16.73M
shares outstanding. The number of shares has increased by 9.88%
in one year.
Shares Outstanding 16.73M Shares Change (YoY) 9.88% Shares Change (QoQ) 0% Owned by Institutions (%) 27.89% Shares Floating 15.53M Failed to Deliver (FTD) Shares 203 FTD / Avg. Volume 0.28%
Short Selling Information The latest short interest is 217.24K, so 1.3% of the outstanding
shares have been sold short.
Short Interest 217.24K Short % of Shares Out 1.3% Short % of Float 1.4% Short Ratio (days to cover) 6.81
Valuation Ratios The PE ratio is -5.87 and the forward
PE ratio is -3.39.
Coya Therapeutics's PEG ratio is
-0.24.
PE Ratio -5.87 Forward PE -3.39 PS Ratio 24.57 Forward PS 52.8 PB Ratio 2.21 P/FCF Ratio -8.49 PEG Ratio -0.24
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Coya Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.59,
with a Debt / Equity ratio of 0.
Current Ratio 11.59 Quick Ratio 11.59 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $444.25K Profits Per Employee $-1.86M Employee Count 8 Asset Turnover 0.08 Inventory Turnover n/a
Taxes Income Tax -720K Effective Tax Rate 4.62%
Stock Price Statistics The stock price has increased by 4.33% in the
last 52 weeks. The beta is 0.27, so Coya Therapeutics's
price volatility has been higher than the market average.
Beta 0.27 52-Week Price Change 4.33% 50-Day Moving Average 6.19 200-Day Moving Average 6.08 Relative Strength Index (RSI) 48.48 Average Volume (20 Days) 71,322
Income Statement In the last 12 months, Coya Therapeutics had revenue of 3.55M
and earned -14.88M
in profits. Earnings per share was -0.98.
Revenue 3.55M Gross Profit 3.55M Operating Income -17.25M Net Income -14.88M EBITDA -17.22M EBIT -17.23M Earnings Per Share (EPS) -0.98
Full Income Statement Balance Sheet The company has 38.34M in cash and 0 in
debt, giving a net cash position of 38.34M.
Cash & Cash Equivalents 38.34M Total Debt n/a Net Cash n/a Retained Earnings -40.74B Total Assets 33.45B Working Capital 28.93B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.29M
and capital expenditures 0, giving a free cash flow of -10.29M.
Operating Cash Flow -10.29M Capital Expenditures n/a Free Cash Flow -10.29M FCF Per Share -0.68
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -485.37% and -418.71%.
Gross Margin 100% Operating Margin -485.37% Pretax Margin -438.97% Profit Margin -418.71% EBITDA Margin -484.58% EBIT Margin -485.37% FCF Margin -289.5%
